×
Magrolimab plus Azacitidine Versus Azacitidine plus Placebo in Untreated Higher Risk Myelodysplastic Syndrome: The Phase 3, Randomized, ENHANCE Study
Garcia-Manero G., Daver N., Xu J., Chao M., Chung T., Tan A., Wang Y., Wei A., Vyas P., Sallman D.
Type
Conference paper
Publication Date
10/2021
Volume
96
Pages
S3 - S3